According to Healio, patients who respond poorly to anti-VEGF therapy may have an elevated risk of obstructive sleep apnea.
Fifty-six AMD patients (54.37%) had non-exudative AMD, and 47 AMD patients (45.63%) had exudative AMD. Among the 47 patients with exudative AMD, 14 (29.79%) responded poorly to anti-VEGF therapy and had a significantly higher risk of obstructive sleep apnea (P < .05).
